273 related articles for article (PubMed ID: 1317502)
1. Two new fluoroquinolones.
Med Lett Drugs Ther; 1992 Jun; 34(872):58-60. PubMed ID: 1317502
[No Abstract] [Full Text] [Related]
2. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM
Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
[No Abstract] [Full Text] [Related]
3. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of the fluoroquinolones.
Scully BE
Urology; 1990 Jan; 35(1 Suppl):8-10. PubMed ID: 2404373
[No Abstract] [Full Text] [Related]
5. Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.
Spivey IM
Clin Pharm; 1993 Jun; 12(6):452-8. PubMed ID: 8403817
[No Abstract] [Full Text] [Related]
6. [Lemofloxacin: antimicrobial ability and clinico-pharmacokinetic basis for use in urogenital infections].
Iakovlev SV
Urologiia; 2002; (1):11-4. PubMed ID: 11877963
[TBL] [Abstract][Full Text] [Related]
7. Grepafloxacin--a new fluoroquinolone.
Med Lett Drugs Ther; 1998 Jan; 40(1019):17-8. PubMed ID: 9465856
[No Abstract] [Full Text] [Related]
8. New uses for new and old quinolones and the challenge of resistance.
Hooper DC
Clin Infect Dis; 2000 Feb; 30(2):243-54. PubMed ID: 10671323
[No Abstract] [Full Text] [Related]
9. A review of clinical trials with fluoroquinolones with an emphasis on new agents.
Blondeau JM
Expert Opin Investig Drugs; 2000 Feb; 9(2):383-413. PubMed ID: 11060684
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of ofloxacin, ciprofloxacin and NY-198 in experimentally infected normal and alloxan-induced diabetic mice.
Obana Y; Nishino T
Drugs Exp Clin Res; 1988; 14(5):327-31. PubMed ID: 3219995
[TBL] [Abstract][Full Text] [Related]
11. Breakpoint determination: rufloxacin.
Eur J Clin Microbiol Infect Dis; 1993 Jul; 12(7):574-5. PubMed ID: 8404928
[No Abstract] [Full Text] [Related]
12. Fluoroquinolones: how to use (but not overuse) these antibiotics.
Sable CA; Scheld WM
Geriatrics; 1993 Jun; 48(6):41-4, 49-51. PubMed ID: 8500773
[TBL] [Abstract][Full Text] [Related]
13. [Significant role of newer quinolone antimicrobials in respiratory tract infection: focused on sparfloxacin].
Jpn J Antibiot; 1994 Oct; 47(10):1241-58. PubMed ID: 7807686
[No Abstract] [Full Text] [Related]
14. Temafloxacin vs ciprofloxacin for UTI.
Ganiats TG; Norcross WA
J Fam Pract; 1992 Jul; 35(1):14, 16, 18. PubMed ID: 1319461
[No Abstract] [Full Text] [Related]
15. In vitro sensitivities of urinary tract pathogens to lomefloxacin and five other antimicrobial agents.
Peddie BA
N Z Med J; 1989 Jun; 102(869):298. PubMed ID: 2733911
[No Abstract] [Full Text] [Related]
16. Temafloxacin vs ciprofloxacin for UTI.
Hornstein LE
J Fam Pract; 1992 Jul; 35(1):14; author reply 18. PubMed ID: 1319460
[No Abstract] [Full Text] [Related]
17. [Grepafloxacin (Raxar)].
Friis HM
Ugeskr Laeger; 1998 Jul; 160(30):4438-41. PubMed ID: 9691842
[No Abstract] [Full Text] [Related]
18. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
Azadian BS; Talboys CA; Roberts AP
J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
[No Abstract] [Full Text] [Related]
19. Laboratory and clinical study of balofloxacin (Q-35), a new fluoroquinolone, in urinary tract infection.
Suzuki K; Horiba M; Ishikawa K; Katoh S; Naide Y; Yanaoka M; Andoh S
Drugs; 1995; 49 Suppl 2():376-8. PubMed ID: 8549367
[No Abstract] [Full Text] [Related]
20. Prulifloxacin. NAD-441A, NM 441, Quisnon.
Drugs R D; 2002; 3(6):426-30. PubMed ID: 12516950
[No Abstract] [Full Text] [Related]
[Next] [New Search]